sirolimus and Thalassemia

sirolimus has been researched along with Thalassemia* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and Thalassemia

Article	Year
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β Genes, 2022, Sep-26, Volume: 13, Issue:10 Gene editing (GE) is an efficient strategy for correcting genetic mutations in monogenic hereditary diseases, including β-thalassemia. We have elsewhere reported that CRISPR-Cas9-based gene editing can be employed for the efficient correction of the β Topics: Adult; beta-Thalassemia; CRISPR-Cas Systems; Erythroid Cells; Fetal Hemoglobin; Gene Editing; Humans; Sirolimus; Thalassemia	2022

Article

Year

Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β

Genes, 2022, Sep-26, Volume: 13, Issue:10

Gene editing (GE) is an efficient strategy for correcting genetic mutations in monogenic hereditary diseases, including β-thalassemia. We have elsewhere reported that CRISPR-Cas9-based gene editing can be employed for the efficient correction of the β

Topics: Adult; beta-Thalassemia; CRISPR-Cas Systems; Erythroid Cells; Fetal Hemoglobin; Gene Editing; Humans; Sirolimus; Thalassemia

2022